Literature DB >> 23515926

The dimeric structure of factor XI and zymogen activation.

Yipeng Geng1, Ingrid M Verhamme, Stephen B Smith, Mao-Fu Sun, Anton Matafonov, Qiufang Cheng, Stephanie A Smith, James H Morrissey, David Gailani.   

Abstract

Factor XI (fXI) is a homodimeric zymogen that is converted to a protease with 1 (1/2-fXIa) or 2 (fXIa) active subunits by factor XIIa (fXIIa) or thrombin. It has been proposed that the dimeric structure is required for normal fXI activation. Consistent with this premise, fXI monomers do not reconstitute fXI-deficient mice in a fXIIa-dependent thrombosis model. FXI activation by fXIIa or thrombin is a slow reaction that can be accelerated by polyanions. Phosphate polymers released from platelets (poly-P) can enhance fXI activation by thrombin and promote fXI autoactivation. Poly-P increased initial rates of fXI activation 30- and 3000-fold for fXIIa and thrombin, respectively. FXI monomers were activated more slowly than dimers by fXIIa in the presence of poly-P. However, this defect was not observed when thrombin was the activating protease, nor during fXI autoactivation. The data suggest that fXIIa and thrombin activate fXI by different mechanisms. FXIIa may activate fXI through a trans-activation mechanism in which the protease binds to 1 subunit of the dimer, while activating the other subunit. For activation by thrombin, or during autoactivation, the data support a cis-activation mechanism in which the activating protease binds to and activates the same fXI subunit.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23515926      PMCID: PMC3650707          DOI: 10.1182/blood-2012-12-473629

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  45 in total

1.  The role of high molecular weight kininogen and prothrombin as cofactors in the binding of factor XI A3 domain to the platelet surface.

Authors:  D H Ho; K Badellino; F A Baglia; M F Sun; M M Zhao; D Gailani; P N Walsh
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

2.  FXI is essential for thrombus formation following FeCl3-induced injury of the carotid artery in the mouse.

Authors:  Elliot D Rosen; Dave Gailani; Francis J Castellino
Journal:  Thromb Haemost       Date:  2002-04       Impact factor: 5.249

3.  Differential activation and inhibition of human platelet thrombin receptors by structurally distinct alpha-, beta- and gamma-thrombin.

Authors:  Gerald Soslau; Seth J Goldenberg; Reiner Class; Bradford Jameson
Journal:  Platelets       Date:  2004-05       Impact factor: 3.862

4.  Human blood coagulation factor XI. Purification, properties, and mechanism of activation by activated factor XII.

Authors:  B N Bouma; J H Griffin
Journal:  J Biol Chem       Date:  1977-09-25       Impact factor: 5.157

Review 5.  Inorganic polyphosphate: a molecule of many functions.

Authors:  A Kornberg; N N Rao; D Ault-Riché
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

6.  Amino acid sequence of human factor XI, a blood coagulation factor with four tandem repeats that are highly homologous with plasma prekallikrein.

Authors:  K Fujikawa; D W Chung; L E Hendrickson; E W Davie
Journal:  Biochemistry       Date:  1986-05-06       Impact factor: 3.162

7.  Failure to detect variant (CRM+) plasma thromboplastin antecedent (factor XI) molecules in hereditary plasma thromboplastin antecedent deficiency: a study of 125 patients of several ethnic backgrounds.

Authors:  H Saito; O D Ratnoff; B N Bouma; U Seligsohn
Journal:  J Lab Clin Med       Date:  1985-12

8.  Molecular cloning and biochemical characterization of rabbit factor XI.

Authors:  Dipali Sinha; Mariola Marcinkiewicz; David Gailani; Peter N Walsh
Journal:  Biochem J       Date:  2002-10-01       Impact factor: 3.857

9.  Dominant factor XI deficiency caused by mutations in the factor XI catalytic domain.

Authors:  Dmitri V Kravtsov; Wenman Wu; Joost C M Meijers; Mao-Fu Sun; Morey A Blinder; Thao P Dang; Hongli Wang; David Gailani
Journal:  Blood       Date:  2004-03-16       Impact factor: 22.113

10.  Factor XI apple domains and protein dimerization.

Authors:  Q Cheng; M-F Sun; D V Kravtsov; A Aktimur; D Gailani
Journal:  J Thromb Haemost       Date:  2003-11       Impact factor: 5.824

View more
  28 in total

1.  Allosteric inhibition of factor XIa. Sulfated non-saccharide glycosaminoglycan mimetics as promising anticoagulants.

Authors:  Rami A Al-Horani; David Gailani; Umesh R Desai
Journal:  Thromb Res       Date:  2015-04-22       Impact factor: 3.944

Review 2.  Factor XI and contact activation as targets for antithrombotic therapy.

Authors:  D Gailani; C E Bane; A Gruber
Journal:  J Thromb Haemost       Date:  2015-06-16       Impact factor: 5.824

3.  Factor XI anion-binding sites are required for productive interactions with polyphosphate.

Authors:  Y Geng; I M Verhamme; S A Smith; Q Cheng; M Sun; J P Sheehan; J H Morrissey; D Gailani
Journal:  J Thromb Haemost       Date:  2013-11       Impact factor: 5.824

Review 4.  Mechanisms and biomarkers of cancer-associated thrombosis.

Authors:  Ann S Kim; Alok A Khorana; Keith R McCrae
Journal:  Transl Res       Date:  2020-07-06       Impact factor: 7.012

5.  Polyphosphate and RNA Differentially Modulate the Contact Pathway of Blood Clotting.

Authors:  Joshua M Gajsiewicz; Stephanie A Smith; James H Morrissey
Journal:  J Biol Chem       Date:  2016-12-22       Impact factor: 5.157

6.  Nucleic acids as cofactors for factor XI and prekallikrein activation: Different roles for high-molecular-weight kininogen.

Authors:  Ivan Ivanov; Ruhama Shakhawat; Mao-Fu Sun; S Kent Dickeson; Cristina Puy; Owen J T McCarty; Andras Gruber; Anton Matafonov; David Gailani
Journal:  Thromb Haemost       Date:  2017-01-26       Impact factor: 5.249

7.  Murine models in the evaluation of heparan sulfate-based anticoagulants.

Authors:  David Gailani; Qiufang Cheng; Ivan S Ivanov
Journal:  Methods Mol Biol       Date:  2015

8.  Generation and characterization of aptamers targeting factor XIa.

Authors:  R S Woodruff; I Ivanov; I M Verhamme; M-F Sun; D Gailani; B A Sullenger
Journal:  Thromb Res       Date:  2017-06-09       Impact factor: 3.944

Review 9.  The hemostatic role of factor XI.

Authors:  Cristina Puy; Rachel A Rigg; Owen J T McCarty
Journal:  Thromb Res       Date:  2016-05       Impact factor: 3.944

Review 10.  Why factor XI deficiency is a clinical concern.

Authors:  Allison P Wheeler; David Gailani
Journal:  Expert Rev Hematol       Date:  2016-06-24       Impact factor: 2.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.